SBRT Misses the Mark in Prostate Cancer Trial

(MedPage Today) -- Stereotactic body radiotherapy (SBRT) for localized prostate cancer did not improve urinary irritation or disease-free-survival (DFS) compared with hypofractionated intensity-modulated radiotherapy (IMRT), a large randomized...